InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-15.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Hughes Douglas J., Director. Officer active across 2 companies, notably Immunovant, Inc.. Aggregated, 10 filings have been logged. Breakdown: 1 buy · 2 sells. Total volume traded: €536k. History available since 27 August 2021. The latest transaction was disclosed on 7 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Hughes Douglas J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
13,880 shares0Common StockSEC:0001764013-26-000048:0
13,091 shares@ US$23.140.0047% mcap33.6% of flowCommon StockSEC:0001764013-25-000159:0
16,188 shares0Common StockSEC:0001764013-25-000045:0
5,425 shares@ US$28.5415.9% of flowCommon StockSEC:0001764013-24-000199:0
11,255 shares0Common StockSEC:0001764013-24-000065:0
12,523 shares0Common StockSEC:0001764013-23-000046:0
71,363 shares@ US$0.50100.0% of flowCommon StockSEC:0000899243-22-037001:0
21,059 shares0Common StockSEC:0001764013-22-000091:0
21,726 shares0Common StockSEC:0001764013-22-000017:0
18,247 shares@ US$8.2423.9% of flowCommon StockSEC:0001764013-21-000092:0
Canonical exit: 25 Nov 2021 (T+90)
10 of 10 declarations
About Hughes Douglas J.
Douglas J. Hughes is a Board Member at Immunovant, Inc. He brings a strategic perspective to the board, contributing to the direction and governance of the company. His diverse experience enriches discussions and decisions within the board.
